Category: Professional Posters
Purpose: The implementation of antimicrobial stewardship program (ASP) is one of the basis for the control of multidrug resistant bacteria (MDR), optimization of antibiotic use, minimization of adverse events, and reduction of unnecessary costs. We demonstrate the design, development, and participation in ASP program following CDC and Prevention Core Elements strategies.1,3,4 The objective is to evaluate the impact of clinical pharmacists working in conjunction with Infectious Disease (ID) physician on tracking and documenting antibacterial utilization in per patient days, pharmacist clinical interventions, prescriber practices, and antibiotic purchases.
Methods: We conducted a multidisciplinary-team project of pharmacist-led prospective-audit-with-feedback ASP from 2015 to 2018. The ID physician and clinical pharmacist conducted patient care rounds twice weekly to make recommendations that include de-escalation, intensification of treatment, alternative therapy, dose optimization, order clarification, stop date/duration, additional monitoring, education, restriction enforcement, consult, IV to PO conversion, rejection of recommendation, and total monitored interventions requiring no changes.
Regular education to hospitalists, yearly patient safety fairs, employing rapid testing of blood culture using VeriGene, publication of yearly Antibiogram, mass emails to clinicians, and pharmacist managed renal dosing and vancomycin and aminoglycoside protocols are strategies we incorporated.
Results: Pharmacist tracked between 150-200 interventions monthly through EMR system, reflecting both self-stewardship and during rounds with ID physician. Figures 2-8: Charts display the number of patient days of therapy per 1000 days at risk and yearly SVMH Antibacterial Utilization Rates compared nationally to other Teaching and Nonteaching hospitals. Below each graph exhibits yearly Drug Spend per patient Days of Therapy.
Conclusion: Antibiotic utilization rates decreased over four years, particularly with aztreonam, meropenem, and levofloxacin. The formalization of an antimicrobial stewardship partnership between ID physician and pharmacy team led to increases in pharmacist-recommended interventions, streamlining of antimicrobial therapy, as well as decreases in antimicrobial purchasing costs. Proactively working in conjunction with hospitalists allows the pharmacists to play a critical role in sustaining a robust ASP service at our community hospital. The ASP at SVMH can serve as a model for other community hospitals with similar resources.